The p38 MAPK regulates IL-24 expression by stabilization of the 3′ UTR of IL-24 mRNA

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Otkjaer, Kristian ^a   Holtmann, Helmut ^b   Kragstrup, Tue Wenzel ^c   Paludan, Søren Riis ^c   Johansen, Claus ^a   Gaestel, Matthias ^b   Kragballe, Knud ^a   Iversen, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 24; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; IMIDAZOLE DERIVATIVE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; RNA DEGRADATION; RNA STABILITY; UNTRANSLATED REGION; 3' UNTRANSLATED REGION; CELL LINE; DRUG ANTAGONISM; ENZYME ACTIVATION; GENETICS; METABOLISM;

3' UNTRANSLATED REGIONS; ANISOMYCIN; CELL LINE; ENZYME ACTIVATION; HUMANS; IMIDAZOLES; INTERLEUKIN-1BETA; INTERLEUKINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PYRIDINES; RNA, MESSENGER;

EID: 77952508390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008671     Document Type: Article

References (45)

1. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB (1995) Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11: 2477-2486.
2. Sauane M, Gopalkrishnan RV, Sarkar D, Su ZZ, Lebedeva IV, et al. (2003) MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev 14: 35-51.
3. Wang M, Tan Z, Zhang R, Kotenko SV, Liang P (2002) Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem 277: 7341-7347.
4. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC (2001) Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167: 3545-3549.
5. Ekmekcioglu S, Ellerhorst J, Mhashilkar AM, Sahin AA, Read CM, et al. (2001) Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int J Cancer 94: 54-59.
6. Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, et al. (2002) The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 21: 708-718.
7. Sauane M, Gopalkrishnan RV, Lebedeva I, Mei MX, Sarkar D, et al. (2003) Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STATindependent pathways. J Cell Physiol 196: 334-345.
8. Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, et al. (2002) mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci U S A 99: 10054-10059.
9. Lebedeva IV, Emdad L, Su ZZ, Gupta P, Sauane M, et al. (2007) mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol 31: 985-1007.
10. Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, et al. (2005) Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Mol Ther 11: 149-159.
11. Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, et al. (2005) Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients. Mol Ther 11: 160-172.
12. Ellerhorst JA, Prieto VG, Ekmekcioglu S, Broemeling L, Yekell S, et al. (2002) Loss of MDA-7 expression with progression of melanoma. J Clin Oncol 20: 1069-1074.
13. Sa SM, Valdez PA, Wu J, Jung K, Zhong F, et al. (2007) The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis. J Immunol 178: 2229-2240.
14. Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilkar AM, et al. (2002) The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol 168: 6041-6046.
15. Kragstrup TW, Otkjaer K, Holm C, Jorgensen A, Hokland M, et al. (2008) The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine 41: 16-23.
16. Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, et al. (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203: 2577-2587.
17. Romer J, Hasselager E, Norby PL, Steiniche T, Thorn Clausen J, et al. (2003) Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J Invest Dermatol 121: 1306-1311.
18. Kunz S, Wolk K, Witte E, Witte K, Doecke WD, et al. (2006) Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 15: 991-1004.
19. Poindexter NJ, Walch ET, Chada S, Grimm EA (2005) Cytokine induction of interleukin-24 in human peripheral blood mononuclear cells. J Leukoc Biol 78: 745-752.
20. Madireddi MT, Dent P, Fisher PB (2000) AP-1 and C/EBP transcription factors contribute to mda-7 gene promoter activity during human melanoma differentiation. J Cell Physiol 185: 36-46.
21. Madireddi MT, Dent P, Fisher PB (2000) Regulation of mda-7 gene expression during human melanoma differentiation. Oncogene 19: 1362-1368.
22. Zhang R, Tan Z, Liang P (2000) Identification of a novel ligand-receptor pair constitutively activated by ras oncogenes. J Biol Chem 275: 24436-24443.
23. Winzen R, Gowrishankar G, Bollig F, Redich N, Resch K, et al. (2004) Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol Cell Biol 24: 4835-4847.
24. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, et al. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. Embo J 18: 4969-4980.
25. Dean JL, Sully G, Clark AR, Saklatvala J (2004) The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathwaymediated mRNA stabilisation. Cell Signal 16: 1113-1121.
26. Sandler H, Stoecklin G (2008) Control of mRNA decay by phosphorylation of tristetraprolin. Biochem Soc Trans 36: 491-496.
27. Otkjaer K, Kragballe K, Johansen C, Funding AT, Just H, et al. (2007) IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms. J Invest Dermatol 127: 1326-1336.
28. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ (1996) MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 16: 1247-1255.
29. Hazzalin CA, Le Panse R, Cano E, Mahadevan LC (1998) Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction. Mol Cell Biol 18: 1844-1854.
30. Funding AT, Johansen C, Kragballe K, Otkjaer K, Jensen UB, et al. (2006) Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines. J Invest Dermatol 126: 1784-1791.
31. Winzen R, Thakur BK, Dittrich-Breiholz O, Shah M, Redich N, et al. (2007) Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets. Mol Cell Biol 27: 8388-8400.
32. Zarubin T, Han J (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res 15: 11-18.
33. Smalley K, Eisen T (2000) The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS Lett 476: 198-202.
34. Smalley KS, Eisen TG (2002) Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest. Melanoma Res 12: 187-192.
35. Gupta P, Walter MR, Su ZZ, Lebedeva IV, Emdad L, et al. (2006) BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res 66: 8182-8191.
36. Sainz-Perez A, Gary-Gouy H, Portier A, Davi F, Merle-Beral H, et al. (2006) High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia. Leukemia 20: 498-504.
37. Loesch M, Chen G (2008) The p38 MAPK stress pathway as a tumor suppressor or more? Front Biosci 13: 3581-3593.
38. Sauane M, Su ZZ, Gupta P, Lebedeva IV, Dent P, et al. (2008) Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc Natl Acad Sci U S A 105: 9763-9768.
39. Johansen C, Funding AT, Otkjaer K, Kragballe K, Jensen UB, et al. (2006) Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol 176: 1431-1438.
40. Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, et al. (2005) The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol 152: 37-42.
41. Blumberg H, Conklin D, Xu WF, Grossmann A, Brender T, et al. (2001) Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104: 9-19.
42. Kragballe K, Desjarlais L, Marcelo CL (1985) Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro. Br J Dermatol 112: 263-270.
43. Otkjaer K, Kragballe K, Funding AT, Clausen JT, Noerby PL, et al. (2005) The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br J Dermatol 153: 911-918.
44. Xu N, Loflin P, Chen CY, Shyu AB (1998) A broader role for AU-rich elementmediated mRNA turnover revealed by a new transcriptional pulse strategy. Nucleic Acids Res 26: 558-565.
45. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547-5551.